Alkermes plc. Revenue
Alkermes plc. (ALKS) reported Revenue of $496.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-28
- Alkermes plc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $496.01M, a 26.97% increase year-over-year.
- Alkermes plc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $392.91M, a 28.19% increase year-over-year.
- Alkermes plc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $384.55M, a 10.57% decline year-over-year.
- Alkermes plc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $394.19M, a 4.24% increase year-over-year.
- Alkermes plc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.48B, a 5.25% decline from fiscal 2024.
- Alkermes plc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.56B, a 6.36% decline from fiscal 2023.
- Alkermes plc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.66B, a 49.61% increase from fiscal 2022.
- Alkermes plc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.11B, a 5.28% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $496.01M 10-Q · filed 2026-07-28 | $888.92M 10-Q · filed 2026-07-28 | $1.27B derived: sum of 3 quarters · filed 2026-07-28 | $1.67B derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $392.91M 10-Q · filed 2026-05-05 | $777.46M derived: sum of 2 quarters · filed 2026-05-05 | $1.17B derived: sum of 3 quarters · filed 2026-05-05 | $1.56B derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $384.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $778.73M derived: sum of 2 quarters · filed 2026-02-25 | $1.17B derived: sum of 3 quarters · filed 2026-07-28 | $1.48B 10-K · filed 2026-02-25 |
| 2025-09-30 | $394.19M 10-Q · filed 2025-10-28 | $784.84M derived: sum of 2 quarters · filed 2026-07-28 | $1.09B 10-Q · filed 2025-10-28 | $1.52B derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $390.66M 10-Q · filed 2026-07-28 | $697.17M 10-Q · filed 2026-07-28 | $1.13B derived: sum of 3 quarters · filed 2026-07-28 | $1.51B derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $306.51M 10-Q · filed 2026-05-05 | $736.50M derived: sum of 2 quarters · filed 2026-05-05 | $1.11B derived: sum of 3 quarters · filed 2026-05-05 | $1.51B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $429.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $808.13M derived: sum of 2 quarters · filed 2026-02-25 | $1.21B derived: sum of 3 quarters · filed 2026-02-25 | $1.56B 10-K · filed 2026-02-25 |
| 2024-09-30 | $378.14M 10-Q · filed 2025-10-28 | $777.27M derived: sum of 2 quarters · filed 2025-10-28 | $1.13B 10-Q · filed 2025-10-28 | $1.51B derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $399.13M 10-Q · filed 2025-07-29 | $749.50M 10-Q · filed 2025-07-29 | $1.13B derived: sum of 3 quarters · filed 2026-02-25 | $1.51B derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $350.37M 10-Q · filed 2025-05-01 | $727.85M derived: sum of 2 quarters · filed 2026-02-25 | $1.11B derived: sum of 3 quarters · filed 2026-02-25 | $1.73B derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $377.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $758.41M derived: sum of 2 quarters · filed 2026-02-25 | $1.38B derived: sum of 3 quarters · filed 2026-02-25 | $1.66B 10-K · filed 2026-02-25 |
| 2023-09-30 | $380.94M 10-Q · filed 2024-10-24 | $998.34M derived: sum of 2 quarters · filed 2024-10-24 | $1.29B 10-Q · filed 2024-10-24 | $1.59B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $617.40M 10-Q · filed 2024-07-24 | $904.99M 10-Q · filed 2024-07-24 | $1.21B derived: sum of 3 quarters · filed 2025-02-12 | $1.46B derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $287.60M 10-Q · filed 2024-05-01 | $592.27M derived: sum of 2 quarters · filed 2025-02-12 | $844.63M derived: sum of 3 quarters · filed 2025-02-12 | $1.12B derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $304.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $557.03M derived: sum of 2 quarters · filed 2025-02-12 | $833.25M derived: sum of 3 quarters · filed 2025-02-12 | $1.11B 10-K · filed 2025-02-12 |
| 2022-09-30 | $252.36M 10-Q · filed 2023-10-25 | $528.58M derived: sum of 2 quarters · filed 2023-10-25 | $807.12M 10-Q · filed 2023-10-25 | $1.13B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $276.22M 10-Q · filed 2023-07-26 | $554.76M 10-Q · filed 2023-07-26 | $879.23M derived: sum of 3 quarters · filed 2024-02-21 | $1.17B derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $278.55M 10-Q · filed 2023-04-26 | $603.01M derived: sum of 2 quarters · filed 2024-02-21 | $897.15M derived: sum of 3 quarters · filed 2024-02-21 | $1.20B derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $324.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $618.60M derived: sum of 2 quarters · filed 2024-02-21 | $922.32M derived: sum of 3 quarters · filed 2024-02-21 | $1.17B 10-K · filed 2024-02-21 |
| 2021-09-30 | $294.14M 10-Q · filed 2022-11-02 | $597.86M derived: sum of 2 quarters · filed 2022-11-02 | $849.29M 10-Q · filed 2022-11-02 | $1.13B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $303.72M 10-Q · filed 2022-07-27 | $555.15M 10-Q · filed 2022-07-27 | $835.14M derived: sum of 3 quarters · filed 2023-02-16 | $1.10B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $251.43M 10-Q · filed 2022-04-27 | $531.42M derived: sum of 2 quarters · filed 2023-02-16 | $796.44M derived: sum of 3 quarters · filed 2023-02-16 | $1.04B derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $280.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $545.01M derived: sum of 2 quarters · filed 2023-02-16 | $792.54M derived: sum of 3 quarters · filed 2023-02-16 | $1.04B 10-K · filed 2023-02-16 |
| 2020-09-30 | $265.01M 10-Q · filed 2021-10-27 | $512.54M derived: sum of 2 quarters · filed 2021-10-27 | $758.76M 10-Q · filed 2021-10-27 | $1.17B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $247.53M 10-Q · filed 2021-07-28 | $493.75M 10-Q · filed 2021-07-28 | $906.48M derived: sum of 3 quarters · filed 2022-02-16 | $1.16B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $246.22M 10-Q · filed 2021-04-28 | $658.95M derived: sum of 2 quarters · filed 2022-02-16 | $914.19M derived: sum of 3 quarters · filed 2022-02-16 | $1.19B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $412.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $667.97M derived: sum of 2 quarters · filed 2022-02-16 | $947.85M derived: sum of 3 quarters · filed 2022-02-16 | $1.17B 10-K · filed 2022-02-16 |
| 2019-09-30 | $255.24M 10-Q · filed 2020-10-29 | $535.12M derived: sum of 2 quarters · filed 2020-10-29 | $758.22M 10-Q · filed 2020-10-29 | $1.07B derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $279.87M 10-Q · filed 2020-07-29 | $502.97M 10-Q · filed 2020-07-29 | $818.74M derived: sum of 3 quarters · filed 2021-02-11 | $1.07B derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $223.10M 10-Q · filed 2020-04-29 | $538.86M derived: sum of 2 quarters · filed 2021-02-11 | $787.58M derived: sum of 3 quarters · filed 2021-02-11 | $1.09B derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $315.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $564.48M derived: sum of 2 quarters · filed 2021-02-11 | $869.12M derived: sum of 3 quarters · filed 2021-02-11 | $1.09B 10-K · filed 2021-02-11 |
| 2018-09-30 | $248.72M 10-Q · filed 2019-10-23 | $553.36M derived: sum of 2 quarters · filed 2019-10-23 | $778.51M 10-Q · filed 2019-10-23 | $1.05B derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $304.64M 10-Q · filed 2019-07-25 | $529.79M 10-Q · filed 2019-07-25 | $805.16M derived: sum of 3 quarters · filed 2020-02-13 | $1.02B derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $225.15M 10-Q · filed 2019-04-25 | $500.52M derived: sum of 2 quarters · filed 2020-02-13 | $717.90M derived: sum of 3 quarters · filed 2020-02-13 | $936.75M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $275.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $492.75M derived: sum of 2 quarters · filed 2020-02-13 | $711.60M derived: sum of 3 quarters · filed 2020-02-13 | $903.37M 10-K · filed 2020-02-13 |
| 2017-09-30 | $217.38M 10-Q · filed 2018-10-23 | $436.23M derived: sum of 2 quarters · filed 2018-10-23 | $628.00M 10-Q · filed 2018-10-23 | |
| 2017-06-30 | $218.84M 10-Q · filed 2018-07-26 | $410.62M 10-Q · filed 2018-07-26 | ||
| 2017-03-31 | $191.78M 10-Q · filed 2018-04-26 | |||
| 2016-12-31 | $745.69M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |